QHK-28424-64119
5 vaccinations
1 coded response
52 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 190 / PA
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
QPX-30803-11754
Child or adolescent in my care · Female · 2022-06-27
TYE-17969-01649
Child or adolescent in my care · Female · 2022-06-27
BCD-45849-51302
Child or adolescent in my care · Male · 2023-01-18
Timeline
-
2020-12-30
Dose 1 — Moderna
-
2021-01-02
Registered in v-safe
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-13
- 2021-01-20
-
2021-01-26
Dose 2 — Moderna
- 2021-01-26
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
-
2021-04-27
Survey response — 3 months, dose 2MedDRA: Cough, Oropharyngeal pain, Respiratory symptom, Rhinorrhoea — Feeling: Good · Be unable to workFree text: Upper respiratory symptoms, cough, sore throat, runny nose. Whole family was sick, both kids were COVID tested and were negativeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-27
-
2021-11-23
Dose 3 — Moderna
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-11-30
- 2021-12-07
- 2021-12-14
- 2021-12-21
- 2021-12-31
- 2022-01-04
- 2022-02-22
-
2022-05-18
Dose 4 — Moderna
- 2022-05-24
- 2022-05-24
- 2022-05-25
- 2022-06-01
- 2022-06-08
- 2022-06-15
- 2022-06-22
- 2022-06-29
- 2022-08-17
-
2022-10-19
Dose 5 — Moderna
- 2022-10-22
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2022-12-02
- 2023-01-18
- 2023-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-11-23 | Moderna | No |
| 4 | 2022-05-18 | Moderna | No |
| 5 | 2022-10-19 | Moderna | No |
Free text
Release 8 — 3 months, dose 2
Symptoms: Upper respiratory symptoms, cough, sore throat, runny nose. Whole family was sick, both kids were COVID tested and were negative
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory symptom | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release